A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Pediatric Research and Clinical Trials -
Location
-
Principal Investigator
-
Sponsor
Children's Oncology Group
The overall goals of this study are to
Compare the outcomes of dinutuximab given early with Induction therapy to the effects of standard Induction therapy with the addition of dinutuximab later in therapy in people with HRNBL to find out which is better
Enrollment Form
This study is currently enrolling.